Achema middle east

Drug Research

NHS To Deploy Variant-Busting Booster Jab Ahead of Winter

The NHS has now laid out plans for the next stage of the COVID-19 vaccination effort, the biggest and most rapid vaccine drive in the...

Priority Review of Lynparza If Paired With Abiraterone In US

Priority consideration has been given to AstraZeneca's supplemental new drug application for Lynparza (olaparib) when used in conjunction with abiraterone, prednisone, or prednisolone to treat...

Trends of Genuv Cancer Drug Show Potential For Alzheimers

Mekinist (trametinib), which has been licenced by the FDA for the treatment of melanoma, was shown in a preclinical trial to have a neuroprotective impact...

Axsome Pitches Auvelity As A Depression Med Game-Changer

It is commonly known that there are insufficient therapy choices for major depressive disorder. Then the pandemic struck, increasing the number of patients with MDD...

Gene Therapy By Bluebird Bio Costing $2.8M Given Nod By FDA

Gene therapy for blood disorders developed by Bluebird Bio has already left the nest in the US. Zynteglo, sometimes known as betibeglogene autotemcel (beti-cel), was authorised...

ADCs Built On Starpharma Delivery Tech To Be Tested By Merck

As it works to expand its antibody-drug conjugate (ADC) capabilities, Merck has strengthened its links to Starpharma by signing a second partnership that will allow...

After Roe, Bayer Engages Lobbyists For Contraception Access

While a large portion of the biopharma industry prepares for a battle over medication prices, Bayer is getting ready for a different lobbying push of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »